Ondansetron is marketed under the brand name Zofran by GlaxoSmithKline for the treatment and prevention of chemotherapy-induced nausea and vomiting. The study was designed to compare the pharmacokinetic
The monotherapy trial, which compared single-agent oral talactoferrin to placebo in patients with NSCLC who had failed previous chemotherapy, met its primary endpoint of improvement in overall survival.
The Althea Diagnostics spin-out incorporates a test for differential diagnosis of pediatric solid-tumors, along with a pipeline of other biomarker sets that will be used for cancer management.
Positive data from the Oxycyte pilot study in TBI patients demonstrated that Oxycyte was more effective in increasing brain oxygen tension levels and impacting other brain chemistries that
AstraZeneca also announced that the National Cancer Institute of Canada Clinical Trials Group (NCIC-CTG) has informed AstraZeneca that the BR24 Phase II/III study of Recentin at 30mg in
The agreement gives Alimera the exclusive option to license a class of small molecule compounds, known as triphenylmethanes, as a potential treatment for ocular disorders such as diabetic
The company has not received the office action but anticipates that it will file a response to this final office action upon review of the document. The company
BriteDent agreed to a significant initial deposit upon signing the contract and agreed to another payment by the first of September 2008. BriteDent also committed to a purchase
The EsophyX device is said to enable surgeons and advanced interventional gastroenterologists to offer their patients substantive anatomical repair without incisions (no skin or internal dissection) for front-line
A large Phase IIb COPD dose-optimization study with the lead long-acting beta agonist (LABA) GW642444 (‘444) has commenced, with screening of the first patient undertaken. This double-blind, placebo
Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.